Una Ryan to Head Diagnostics for All

Xconomy Boston — 

Biotech veteran Una Ryan has joined the nonprofit firm Diagnostics for All as CEO, The Boston Globe reports. Ryan, who is leaving her post as chief executive at Boston University spin-out Waltham Technologies, is also the former CEO of Needham, MA-based Avant Immunotherapeutics (now Celldex Therapeutics). She tells the Globe that one of her plans for Diagnostics for All, which develops paper-based diagnostics for the developing world based on technology from the Harvard lab of chemist George Whitesides, is to start a for-profit company to market the nonprofit group’s tests in the developed world.